About
TRPV3 inhibitors
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
9
As Collaborator
2
Total Enrollment
452
By Phase
PHASE1: 6NA: 1PHASE1/PHASE2: 2PHASE3: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 7TERMINATED: 2RECRUITING: 1NOT_YET_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07090889Lead Sponsor
Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.
PHASE1Recruiting
64 participants
Started: Jul 8, 2025 · Completed: Feb 11, 2026
NCT06134401Collaborator
Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability
NANot yet recruiting
40 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2027
NCT05956314Lead Sponsor
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
PHASE1Completed
18 participants
Started: Mar 6, 2023 · Completed: Nov 7, 2024
NCT05435638Lead Sponsor
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
PHASE1Completed
14 participants
Started: Jul 17, 2022 · Completed: Sep 5, 2024
NCT05454462Lead Sponsor
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
PHASE1Completed
55 participants
Started: May 24, 2022 · Completed: Apr 4, 2023
Locations (1)
Headquarters
Ness Ziona, Israel
Map
Loading map...